Abstract
The present study describes the production and characterization of phosphatidylcholine based ethosomes and organogels, as percutaneous delivery systems for crocin. Crocin presence did not influence ethosome morphology, while the drug slightly increased ethosome mean diameter. Importantly, the poor chemical stability of crocin has been found to be long controlled by organogel. To investigate the performance of phosphatidylcholine lipid formulations as crocin delivery system, in vivo studies, based on tape stripping and skin reflectance spectrophotometry, were performed. Tape stripping results suggested a rapid initial penetration of crocin exerted by the organogel, probably due to a strong interaction between the peculiar supramolecular aggregation structure of phospholipids in the vehicle and the lipids present in the stratum corneum and a higher maintenance of crocin concentration in the case of ethosomes, possibly because of the formation of a crocin depot in the stratum corneum. Skin reflectance spectrophotometry data indicated that both vehicles promoted the penetration of crocin through the skin, with a more rapid anti-inflammatory effect exploited by ethosomes, attributed to an ethanol pronounced penetration enhancer effect and to the carrier system as a whole.
Similar content being viewed by others
Abbreviations
- ETHO:
-
Ethosomes
- ORG:
-
Organogels
- CRO:
-
Crocin
- X GUM:
-
Xanthan gum
- PC:
-
Phosphatidylcholine
- MED:
-
Minimal erythemal dose
References
S.H. Alavizadeh, H. Hosseinzadeh, Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem. Toxicol. 64, 65–80 (2014)
A. Asai, T. Nakano, M. Takahashi, A. Nagao, Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J. Agric. Food. Chem. 53, 7302–6 (2005)
S.S. Bodade, K.S. Shaikh, M.S. Kamble, P.D. Chaudhari, A study on ethosomes as mode for transdermal delivery of an antidiabetic drug. Drug Delivery 20, 40–6 (2013)
M. Changez, J. Chander, A.K. Dinda, Transdermal permeation of tetracaine hydrochloride by lecithin microemulsion: in vivo. Colloids Surf. B: Biointerfaces 48, 58–66 (2006)
E. Christodoulou, N.P. Kadoglou, N. Kostomitsopoulos, G. Valsami, Saffron: a natural product with potential pharmaceutical applications. J. Pharm. Pharmacol. 67, 1634–49 (2015)
K.S. Chun, J. Kundu, J.K. Kundu, Y.J. Surh, Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals. Toxicol. Lett. 229, 73–84 (2014)
G.M. El Maghraby, A.C. Williams, Vesicular systems for delivering conventional small organic molecules and larger macromolecules to and through human skin. Expert Opin. Drug Deliv. 6, 149–63 (2009)
J. Escribano, G.L. Alonso, M. Coca-Prados, J.A. Fernandez, Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett. 100, 23–30 (1996)
E. Esposito, R. Cortesi, M. Drechsler, L. Paccamiccio, P. Mariani, C. Contado, E. Stellin, E. Menegatti, F. Bonina, C. Puglia, Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm. Res. 22, 2163–73 (2005)
E. Esposito, P. Mariani, L. Ravani, C. Contado, M. Volta, S. Bido, M. Drechsler, S. Mazzoni, E. Menegatti, M. Morari, R. Cortesi, Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. Eur. J. Pharm. Biopharm. 80, 306–14 (2012)
E. Esposito, E. Menegatti, R. Cortesi, Design and characterization of fenretinide containing organogels. Mater. Sci. Eng. C 33, 383–9 (2013)
E. Esposito, L. Ravani, P. Mariani, N. Huang, P. Boldrini, M. Drechsler, G. Valacchi, R. Cortesi, C. Puglia, Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. Eur. J. Pharm. Biopharm. 86, 121–32 (2014)
Z. Fiume, Final report on the safety assessment of lecithin and hydrogenated lecithin. Int. J. Toxicol. 20, 21–45 (2001)
B. Godin, E. Touitou, Ethosomes: new prospects in transdermal delivery. Crit. Rev. Ther. Drug Carrier Syst. 20, 63–102 (2003)
J. Grdadolnik, J. Kidric, D. Hadzi, Hydration of phosphatidylcholine reverse micelles and multilayers-an infrared spectroscopic study. Chem. Phys. Lipids 59, 57–68 (1991)
G.I. Harrison, A.R. Young, S.B. McMahon, Ultraviolet radiation-induced inflammation as a model for cutaneous hyperalgesia. J. Invest. Dermatol. 122, 183–9 (2004)
K. Hashizaki, N. Tamaki, H. Taguki, Y. Saito, K. Tsuchiya, H. Sakai, M. Abe, Rheological behavior of worm-like micelles in a mixed nonionic surfactant system of a polyoxyethylene phytosterol and a glycerin fatty acid monoester. Chem. Pharm. Bull. 56, 1682–6 (2008)
S. Jain, A.K. Tiwary, B. Sapra, N.K. Jain, Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech 8, 249 E1–E9 (2007)
T. Konoshima, M. Takasaki, H. Tokuda, S. Morimoto, H. Tanaka, E. Kawata, L.J. Xuan, H. Saito, M. Sugiura, J. Molnar, Y. Shoyama, Crocin and crocetin derivatives inhibit skin tumor promotion in mice. Phytother. Res. 12, 400–4 (1998)
R. Kumar, O.P. Katare, Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. AAPS PharmSciTech 6, E298–310 (2005)
P.L. Luisi, R. Scartazzini, G. Haering, P. Schurtenberger, Organogels from water-in-oil microemulsions. Colloid Polym. Sci. 268, 356–74 (1990)
M. Marcotte, R. Taherian Hoshahili, H.S. Ramaswamy, Rheological properties of selected hydrocol as a function of concentration and temperature. Food Res. Int. 34, 695–703 (2001)
S.M. Meeran, M. Vaid, T. Punathil, S.K. Katiyar, Dietary grape seed proanthocyanidins inhibit 12-Otetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis 30, 520–8 (2009)
A.D. Mishra, C.N. Patel, D.R. Shah, Formulation and optimization of ethosomes for transdermal delivery of ropinirole hydrochloride. Curr. Drug Deliv. 10, 500–16 (2013)
A. Mittal, C.A. Elmets, S.K. Katiyar, Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 24, 1379–88 (2003)
K.N. Nam, Y.M. Park, H.J. Jung, J.Y. Lee, B. Min, S. Park, W. Jung, K. Cho, J. Park, I. Kang, J. Hong, E.H. Lee, Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur. J. Pharmacol. 648, 110–6 (2010)
V. Nandakumar, T. Singh, S.K. Katiyar, Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett. 269, 378–87 (2008)
K.D. Patil, S.R. Bakliwal, S.P. Pawar, Organogel: topical and transdermal drug delivery system. Int. J. Pharm. Res. Dev. 3, 58–66 (2011)
R. Pecora, Dynamic light scattering measurement of nanometer particles in liquids. J. Nanopart. Res. 2, 123–31 (2000)
W.J. Pugh, Kinetics of product stability, in Aultons’s Pharmaceutics. The design and manufacture of the medicines, ed. by M.E. Aulton, 3rd edn. (Churchil Livingstone Elsevier, London, 2007), pp. 99–107
S. Raut, S.S. Bhadoriya, V. Uplanchiwar, V. Mishra, A. Gahane, S.K. Jain, Lecithin organogel: a unique micellar system for the delivery of bioactive agents in the treatment of skin aging. Acta Pharm. Sin. B 2, 8–15 (2012)
F.M. Robertson, Skin carcinogenesis, in Encyclopedia of cancer, ed. by M. Schwab (Springer Berlin, Heidelberg, 2012), pp. 3432–5
D. Satapathy, D. Biswas, B. Behera, S.S. Sagiri, K. Pal, K. Pramanik, Sunflower-oil-based lecithin organogels as matrices for controlled drug delivery. J. Appl. Polym. Sci. 129, 585–94 (2013)
Y.A. Schipunov, A micellar system with unique properties. Colloids Surf. A 185, 541–54 (2001)
Y.A. Schipunov, H. Hoffmann, Thinning and thickening effects induced by shearing in lecithin solutions of polymer-like micelles. Rheol. Acta 39, 542–53 (2000)
K.-W. Song, Y.-S. Kim, G.S. Chang, Rheology of concentrated xanthan gum solutions: Steady shear flow behaviour. Fibers Polym. 7, 129–38 (2006)
Y.J. Surh, Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 10, 768–80 (2003)
W. Tian, Q. Hu, Y. Xu, Effect of soybean-lecithin as an enhancer of buccal mucosa absorption of insulin. Biomed. Mater. Eng. 22, 171–8 (2012)
E. Touitou, B. Godin, Dermal drug delivery with ethosomes: therapeutic potential. Therapy 4, 465–72 (2007)
E. Touitou, N. Dayan, L. Bergelson, B. Godin, M. Eliaz, Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J. Control. Release 65, 403–18 (2000)
M. Tsimidou, E. Tsatsaroni, Stability of saffron pigments in aqueous extracts. J. Food Sci. 58, 1073–5 (1993)
P. Verma, K. Pathak, Therapeutic and cosmeceutical potential of ethosomes: an overview. J. Adv. Pharm. Technol. Res. 1, 274–82 (2010)
A. Vintiloiu, J.-C. Leroux, Organogels and their use in drug delivery: a review. J. Control. Release 125, 179–92 (2008)
H. Wanga, T.O. Khorb, L. Shu, Z. Su, F. Fuentes, J.-H. Lee, A.-N.T. Kong, Plants against cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anti Cancer Agents Med. Chem. 12, 1281–305 (2012)
C.-J. Weng, G.-C. Yen, Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: phenolic acids, monophenol, polyphenol and their derivatives. Cancer Treat. Rev. 38, 76–87 (2012)
P. Winterhalter, R.M. Straubinger, Saffron, renewed interest in an ancient spice. Food Rev. Intl. 16, 39–59 (2000)
J. Wohlrab, T. Klapperstück, H.W. Reinhardt, M. Albrecht, Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. Skin Pharmacol. Physiol. 23, 298–305 (2010)
Acknowledgments
The authors are grateful to Sarah Villebrun from Institut Galien Paris-Sud, Châtenay-Malabry, France for rheological characterization.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Online Resource 1
A: Aspect of ethosome (ETHO); ethosome prepared in the presence of crocin (ETHO-CRO); ethosome prepared in the presence of crocin and added with x-gum 1 %, w/w ETHO-CRO-x-gum B: Aspect of organogels obtained with 1:1 and 2:1 molar water to PC ratios (1:1 [water]/[PC]; 2:1 [water]/[PC]) and ORG-CRO: organogel prepared with 3:1 molar water to PC ratio in the presence of crocin (ORG-CRO) (GIF 259 kb)
Rights and permissions
About this article
Cite this article
Esposito, E., Drechsler, M., Huang, N. et al. Ethosomes and organogels for cutaneous administration of crocin. Biomed Microdevices 18, 108 (2016). https://doi.org/10.1007/s10544-016-0134-3
Published:
DOI: https://doi.org/10.1007/s10544-016-0134-3